Thermalin Diabetes
PrivateLast Round
Series C
Sep 28, 2017
Total Funding Raised
$35.75M
Company Overview
Thermalin Diabetes operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was a Series C round in September 2017.
Thermalin Diabetes is a biotechnology company that develops a portfolio of insulin analogs to address the fast-acting and long-acting insulin markets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thermalin Diabetes Comparables
Compare Thermalin Diabetes with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sensulin | 85% | |
| Metabulin | 85% | |
| Arecor Therapeutics PLC | 77% |
For institutional investors. Book with your work email.
Thermalin Diabetes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 28, 2017 | ||||
| Grant | Jul 30, 2014 | ||||
| Series B | Jul 30, 2014 | ||||
| Grant | Apr 25, 2012 | ||||
| Series A | Apr 7, 2011 |
For institutional investors. Book with your work email.
Thermalin Diabetes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JumpStart Ventures | Series A |
| JumpStart | Series A |
| NIH RADx | Grant |
| Green Park & Golf Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 28, 2017
$21M round led by Sanofi
For institutional investors. Book with your work email.
Thermalin Diabetes Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Thermalin Diabetes's valuation, stock price, and market status.
Is Thermalin Diabetes a public or private company?
Thermalin Diabetes is a private company.
What is the current stock price of Thermalin Diabetes?
Thermalin Diabetes is a private company, so its shares have no public market price. Caplight tracks Thermalin Diabetes's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Thermalin Diabetes worth (valuation)?
Valuation information for Thermalin Diabetes is not publicly available.
Can I buy Thermalin Diabetes stock?
Thermalin Diabetes shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Thermalin Diabetes's last funding round?
Thermalin Diabetes's most recent funding round was Series C on September 28, 2017.
Who are the main investors in Thermalin Diabetes?
Key investors in Thermalin Diabetes include JumpStart Ventures, JumpStart, NIH RADx, Green Park & Golf Ventures.
Will Thermalin Diabetes IPO soon?
No public IPO plans have been announced for Thermalin Diabetes.
How can I track Thermalin Diabetes secondary market activity?
Caplight tracks bids, offers, and trades in Thermalin Diabetes's shares on secondary markets.